Skip to main navigation Skip to search Skip to main content

A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Prurigo Nodularis

  • Kern, Johannes (Primary Chief Investigator (PCI))
  • Fernandez-Penas, Pablo (Partner Investigator (PI))
  • Frew, John W. (Partner Investigator (PI))

Project: Research

Project Details

StatusFinished
Effective start/end date19/02/24 → 19/02/26

Keywords

  • clinical trial
  • Prurigo Nodularis
  • Ruxolitinib
  • skin irritation

Clinical Trial Phase

  • Phase III (a & b)